Investment Partners LTD. reduces its stake in Gilead Sciences, Inc. (NASDAQ:GILD)
According to the most recent Securities and Exchange Commission filing, Investment Partners Ltd lowered its interest in Gilead Sciences, INC ...
Tag: GILD, Analyst Rating
Burt Wealth Advisors makes a $271,000 investment in Gilead Sciences, Inc. (NASDAQ:GILD)
According to the most recent disclosure that Burt Wealth Advisors has made with the Securities and Exchange Commission, the firm ...
Lord Abbett & CO. LLC Invests in Gilead Sciences, Inc. (NASDAQ:GILD)
The company Gilead Sciences, INC (NASDAQ: GILD), purchased by Lord Abbett & Co LLC during the third quarter, was disclosed ...
Shell Asset Management Co. has reduced its holdings in Gilead Sciences, Inc. (NASDAQ:GILD).
Shell Asset Management Co. decreased the amount of Gilead Sciences, Inc. (NASDAQ: GILD) that it owned by 16.7% during the ...
Cowen raised the price target on Gilead Sciences (NASDAQ:GILD) to $95.00.
In a study released on Friday, stock analysts at Cowen increased their target price for Gilead Sciences (NASDAQ: GILD) from ...
Korea Investment CORP has acquired shares of Gilead Sciences, Inc. (NASDAQ:GILD).
Korea Investment Corp.Increased its holdings in Gilead Sciences, INC (NASDAQ: GILD) during the third quarter by 39.5%, as stated in ...
Jefferies Financial Group has issued an earnings estimate for Gilead Sciences, Inc. for the first quarter of 2023.
Gilead Sciences, INC (NASDAQ: GILD), which is in the pharmaceutical business, is one example of a company that fits this ...
Gilead Sciences (NASDAQ:GILD) reports earnings, beating estimates by $0.17 per share.
On Thursday, the quarterly results report for the biotechnology company Gilead Sciences was made available for public consumption (NASDAQ: GILD).Briefing.com ...